Sprint Bioscience is building a drug discovery pipeline of innovative targets within oncology. We are focusing on cancer metabolism and autophagy.
Startup: purified protein ready for fragment screening and crystallization.
Established FBDD Project: Chemical series with low μM affinities and X-ray structure determined of protein-fragment complexes.
Develop in vivo Candidate: two to three chemical series ready for in vivo studies in animal models and/or xenografts. The chemical series should be patentable with freedom to operate.
Develop Clinical Candidate: compound ready for scale up and toxicology in preparation for IND.